Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala

被引:27
作者
Meis, S
Sosulina, L
Schulz, S
Höllt, V
Pape, HC
机构
[1] Otto von Guericke Univ, Fak Med, Inst Physiol, D-39120 Magdeburg, Germany
[2] Otto von Guericke Univ, Inst Pharmakol & Toxikol, D-39120 Magdeburg, Germany
[3] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany
[4] Univ Munster, Inst Expt Epilepsieforsch, D-48149 Munster, Germany
关键词
amygdala; electrophysiology; neuropeptide; patch-clamp; potassium inward rectifier;
D O I
10.1111/j.1460-9568.2005.03922.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of somatostatin in the rat lateral amygdala (LA) in vitro were investigated through whole cell recording techniques. Somatostatin induced an inwardly rectifying K+ current in approximately 98% of LA projection neurons. Half-maximal effects were obtained by 189 nm somatostatin. The effects of somatostatin were insensitive to tetrodotoxin, reduced by Ba2+, occluded or abolished by the presence of nonhydrolysable GTP or GDP analogues, respectively, and blocked or mimicked by a somatostatin receptor type 2 antagonist (BIM-23627) or somatostatin receptor type 2 agonist (L-779,976), respectively, while somatostatin receptor type 1, 3 and 4 agonists were ineffective (L-797,591, L-796,778, L-803,087). Responses to somatostatin were associated with membrane hyperpolarization and decrease in input resistance, resulting in a dampening of cell excitability. It is suggested that these cellular mechanisms contribute to the role of somatostatin in decreasing anxiety behaviour as well as to anticonvulsant and antiepileptogenic actions of somatostatin or somatostatin agonists in the amygdala.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 66 条
[1]  
ASANO T, 1986, MOL PHARMACOL, V29, P244
[2]   Somatostatin depresses long-term potentiation and Ca2+ signaling in mouse dentate gyrus [J].
Baratta, MV ;
Lamp, T ;
Tallent, MK .
JOURNAL OF NEUROPHYSIOLOGY, 2002, 88 (06) :3078-3086
[3]   REGULATION OF THE RELEASE OF COEXISTING NEUROTRANSMITTERS [J].
BARTFAI, T ;
IVERFELDT, K ;
FISONE, G ;
SERFOZO, P .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1988, 28 :285-310
[4]   NEUROPEPTIDES IN NEUROLOGICAL DISEASE [J].
BEAL, MF ;
MARTIN, JB .
ANNALS OF NEUROLOGY, 1986, 20 (05) :547-565
[5]   Heightened seizure severity in somatostatin knockout mice [J].
Buckmaster, PS ;
Otero-Corchón, V ;
Rubinstein, M ;
Low, MJ .
EPILEPSY RESEARCH, 2002, 48 (1-2) :43-56
[6]   Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones [J].
Chessell, IP ;
Black, MD ;
Feniuk, W ;
Humphrey, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (08) :1673-1678
[7]  
Chiu T H, 1994, Chin J Physiol, V37, P97
[8]   Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands [J].
Crider, A. Michael .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (05) :507-517
[9]   Cellular biology of somatostatin receptors [J].
Csaba, Z ;
Dournaud, P .
NEUROPEPTIDES, 2001, 35 (01) :1-23
[10]   INFRARED VIDEOMICROSCOPY - A NEW LOOK AT NEURONAL STRUCTURE AND FUNCTION [J].
DODT, HU ;
ZIEGLGANSBERGER, W .
TRENDS IN NEUROSCIENCES, 1994, 17 (11) :453-458